Patten & Patten Inc Novartis Ag Transaction History

Patten & Patten Inc

$1.43 Billion
Q4 2024

A detailed history of Patten & Patten Inc transactions in Novartis Ag stock. As of the latest transaction made, Patten & Patten Inc holds 30,060 shares of NVS stock, worth $3.35 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

30,060

Previous 32,685 8.03%

Holding current value

$3.35 Million

Previous $3.76 Million 22.19%

% of portfolio

0.2%

Previous 0.26%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$96.78 - $117.18 $254,047 - $307,597	-2,625 Reduced 8.03%	30,060 $2.93 Million
Q3 2024 Nov 04, 2024	SELL	$106.13 - $120.89 $201,116 - $229,086	-1,895 Reduced 5.48%	32,685 $3.76 Million
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $85,164 - $98,780	-920 Reduced 2.59%	34,580 $3.68 Million
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $9,527 - $10,847	-100 Reduced 0.28%	35,500 $3.43 Million
Q4 2023 Jan 23, 2024	SELL	$92.27 - $101.54 $171,622 - $188,864	-1,860 Reduced 4.97%	35,600 $3.59 Million
Q3 2023 Oct 27, 2023	BUY	$94.73 - $105.13 $53,048 - $58,872	560 Added 1.52%	37,460 $3.82 Million
Q2 2023 Jul 14, 2023	BUY	$92.52 - $104.91 $42,281 - $47,943	457 Added 1.25%	36,900 $3.72 Million
Q1 2023 Apr 25, 2023	SELL	$80.03 - $92.81 $811,424 - $941,000	-10,139 Reduced 21.77%	36,443 $3.35 Million
Q4 2022 Feb 01, 2023	SELL	$75.55 - $92.52 $253,545 - $310,497	-3,356 Reduced 6.72%	46,582 $4.23 Million
Q3 2022 Oct 19, 2022	SELL	$74.61 - $87.26 $122,882 - $143,717	-1,647 Reduced 3.19%	49,938 $3.8 Million
Q2 2022 Aug 02, 2022	SELL	$80.52 - $93.75 $220,463 - $256,687	-2,738 Reduced 5.04%	51,585 $4.36 Million
Q1 2022 Apr 25, 2022	SELL	$80.11 - $90.62 $10,975 - $12,414	-137 Reduced 0.25%	54,323 $4.77 Million
Q4 2021 Jan 26, 2022	SELL	$79.7 - $88.13 $200,684 - $221,911	-2,518 Reduced 4.42%	54,460 $4.76 Million
Q3 2021 Oct 22, 2021	SELL	$81.78 - $95.14 $172,555 - $200,745	-2,110 Reduced 3.57%	56,978 $4.66 Million
Q2 2021 Jul 13, 2021	SELL	$85.24 - $94.15 $247,963 - $273,882	-2,909 Reduced 4.69%	59,088 $5.39 Million
Q1 2021 Apr 23, 2021	SELL	$83.5 - $98.47 $147,962 - $174,488	-1,772 Reduced 2.78%	61,997 $5.3 Million
Q4 2020 Jan 19, 2021	SELL	$78.07 - $94.43 $156,374 - $189,143	-2,003 Reduced 3.05%	63,769 $6.02 Million
Q3 2020 Oct 08, 2020	SELL	$82.14 - $91.0 $14,045 - $15,561	-171 Reduced 0.26%	65,772 $5.72 Million
Q2 2020 Jul 21, 2020	SELL	$80.93 - $91.1 $42,326 - $47,645	-523 Reduced 0.79%	65,943 $5.76 Million
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $219,713 - $307,822	-3,109 Reduced 4.47%	66,466 $5.48 Million
Q4 2019 Jan 13, 2020	SELL	$84.35 - $95.37 $6,410 - $7,248	-76 Reduced 0.11%	69,575 $6.59 Million
Q3 2019 Oct 15, 2019	SELL	$85.54 - $94.26 $208,546 - $229,805	-2,438 Reduced 3.38%	69,651 $6.05 Million
Q2 2019 Jul 11, 2019	BUY	$75.4 - $92.8 $107,595 - $132,425	1,427 Added 2.02%	72,089 $6.58 Million
Q1 2019 Apr 23, 2019	BUY	$75.32 - $86.15 $192,969 - $220,716	2,562 Added 3.76%	70,662 $6.79 Million
Q4 2018 Jan 17, 2019	BUY	$73.66 - $82.02 $243,814 - $271,486	3,310 Added 5.11%	68,100 $5.84 Million
Q3 2018 Oct 17, 2018	SELL	$66.94 - $77.43 $187,967 - $217,423	-2,808 Reduced 4.15%	64,790 $5.58 Million
Q2 2018 Jul 18, 2018	SELL	$64.91 - $73.36 $455,668 - $514,987	-7,020 Reduced 9.41%	67,598 $5.11 Million
Q1 2018 Apr 20, 2018	BUY	$70.39 - $84.15 $7,109 - $8,499	101 Added 0.14%	74,618 $6.03 Million
Q4 2017 Jan 22, 2018	SELL	$72.33 - $77.64 $316,299 - $339,519	-4,373 Reduced 5.54%	74,517 $6.26 Million
Q3 2017 Oct 12, 2017	BUY	$74.14 - $77.27 $5.85 Million - $6.1 Million	78,890	78,890 $6.77 Million

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Account

Patten & Patten Inc Novartis Ag Transaction History